leadf
logo-loader
RNS
viewHikma Pharmaceuticals PLC

Hikma Pharmaceutical - Director/PDMR Shareholding

RNS Number : 6668Q
Hikma Pharmaceuticals Plc
22 June 2020
 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Extension of existing pledge by Darhold Limited of 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in support of a loan, in favour of EFG Bank. Darhold Limited is defined as a Person Closely Associated with the Executive Chairman, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 2,000,000

d)

Aggregated information

Aggregated volume: 2,000,000

Price: £0.00p

e)

Date of the transaction

22 June 2020

f)

Place of the transaction

Amman

 

 

 Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Extension of existing pledge by Darhold Limited of 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in support of a loan, in favour of EFG BankDarhold Limited is defined as a Person Closely Associated with the Executive Vice Chairman, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 2,000,000

d)

Aggregated information

Aggregated volume: 2,000,000

Price: £0.00p

e)

Date of the transaction

22 June 2020

f)

Place of the transaction

Amman

Mohammed 'Ali' Al-Husry

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mohammed 'Ali' Al-Husry

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Extension of existing pledge by Darhold Limited of 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in support of a loan, in favour of EFG BankDarhold Limited is defined as a Person Closely Associated with the Non-Executive Director, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 2,000,000

d)

Aggregated information

Aggregated volume: 2,000,000

Price: £0.00p

e)

Date of the transaction

22 June 2020

f)

Place of the transaction

Amman

 

Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHBGGDLCBDDGGD

Quick facts: Hikma Pharmaceuticals PLC

Price: -

Market: AIM
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

6 min read